Whit Mayo
Stock Analyst at Leerink Partners
(2.50)
# 2,417
Out of 4,983 analysts
151
Total ratings
51.55%
Success rate
10.41%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $16.13 | +5.39% | 11 | Sep 5, 2025 | |
ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $310.00 | - | 4 | Jul 18, 2025 | |
AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $5.71 | -56.22% | 5 | Mar 31, 2025 | |
AHCO AdaptHealth | Maintains: Buy | $12 → $11 | $9.22 | +19.31% | 11 | Feb 13, 2025 | |
EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $7.60 | +5.26% | 2 | Nov 19, 2024 | |
ARDT Ardent Health | Maintains: Outperform | $23 → $25 | $12.87 | +94.25% | 2 | Nov 12, 2024 | |
HUM Humana | Downgrades: Market Perform | $400 → $250 | $272.32 | -8.20% | 12 | Oct 2, 2024 | |
EHC Encompass Health | Initiates: Outperform | $100 | $123.81 | -19.23% | 1 | Jul 10, 2024 | |
BTSG BrightSpring Health Services | Initiates: Outperform | $15 | $27.10 | -44.65% | 1 | Feb 20, 2024 | |
UNH UnitedHealth Group | Maintains: Outperform | $625 → $560 | $339.78 | +64.81% | 11 | Jun 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $186.26 | - | 11 | May 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $110.49 | -12.21% | 1 | Apr 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $294.21 | +13.86% | 5 | Feb 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $399.75 | -28.46% | 17 | Dec 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $21.56 | +85.53% | 7 | Nov 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $22.32 | +74.73% | 7 | Nov 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $3.12 | -51.92% | 4 | Nov 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $1.12 | +2,578.57% | 5 | Nov 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $182.82 | -69.92% | 14 | Oct 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $103 | $21.71 | +374.44% | 10 | Aug 26, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $89.92 | +94.62% | 1 | Apr 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $16.54 | +14.87% | 1 | Apr 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $2.89 | +38.41% | 6 | Jul 30, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $274.09 | -25.94% | 2 | May 1, 2018 |
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $16.13
Upside: +5.39%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $310.00
Upside: -
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $5.71
Upside: -56.22%
AdaptHealth
Feb 13, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $9.22
Upside: +19.31%
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $7.60
Upside: +5.26%
Ardent Health
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $12.87
Upside: +94.25%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $272.32
Upside: -8.20%
Encompass Health
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $123.81
Upside: -19.23%
BrightSpring Health Services
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $27.10
Upside: -44.65%
UnitedHealth Group
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $339.78
Upside: +64.81%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $186.26
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $110.49
Upside: -12.21%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $294.21
Upside: +13.86%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $399.75
Upside: -28.46%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $21.56
Upside: +85.53%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $22.32
Upside: +74.73%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $3.12
Upside: -51.92%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $1.12
Upside: +2,578.57%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $182.82
Upside: -69.92%
Aug 26, 2022
Maintains: Outperform
Price Target: $95 → $103
Current: $21.71
Upside: +374.44%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $89.92
Upside: +94.62%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $16.54
Upside: +14.87%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $2.89
Upside: +38.41%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $274.09
Upside: -25.94%